Porcine Circovirus 4: Veterinary Reference

Overview and Taxonomy of Porcine Circovirus 4

Porcine circovirus 4 (PCV4) represents the most recently discovered member of the genus Circovirus within the family Circoviridae, and its emergence has substantially broadened the known genetic and ecological diversity of porcine circoviruses. First identified in 2019 from a herd of pigs exhibiting clinical signs consistent with porcine respiratory disease complex (PRDC) and porcine dermatitis and nephropathy syndrome (PDNS) in Hunan Province, China, PCV4 was initially characterized through metagenomic sequencing and subsequent phylogenetic analysis that revealed a distinct genetic lineage compared to the previously recognized porcine circovirus types 1 (PCV1), 2 (PCV2), and 3 (PCV3) [1, 5]. The index strain, designated HNU-AHG1-2019, possessed a circular single-stranded DNA genome of 1,770 nucleotides, a size consistent with other circoviruses, yet exhibited sufficiently low sequence identity with known circoviruses to warrant classification as a novel species [1, 5]. This discovery was rapidly followed by retrospective and prospective epidemiological investigations across multiple Chinese provinces and subsequently in South Korea, confirming that PCV4 had been circulating undetected for several years prior to its formal identification [2, 4].

Phylogenetic Placement and Genomic Architecture

The taxonomic positioning of PCV4 within the Circoviridae family has been elucidated through comprehensive phylogenetic analyses of complete genome sequences and individual open reading frames (ORFs). Maximum-likelihood and neighbor-joining trees constructed from full-genome alignments consistently place PCV4 in a monophyletic clade that is distinct from PCV1, PCV2, and PCV3, yet shares a more recent common ancestor with mink circovirus (MiCV) than with other porcine circoviruses [4, 7]. This evolutionary relationship suggests a potential cross-species transmission event or a shared ancestral lineage that diverged prior to the speciation of modern circoviruses. The genomic organization of PCV4 is canonical for circoviruses, featuring two major ORFs: ORF1, which encodes the replication-associated protein (Rep) of approximately 296 amino acids, and ORF2, which encodes the capsid protein (Cap) of roughly 228 amino acids [1, 6]. The Rep protein contains conserved rolling-circle replication motifs (RCR) and dNTP-binding domains (Walker A and B boxes), which are hallmarks of circovirus replication machinery, while the Cap protein exhibits the highest genetic variability and is the primary determinant of antigenic diversity and host immune recognition [6, 12]. A characteristic stem-loop structure, essential for initiation of rolling-circle replication, has been predicted in the 5′ intergenic region of the PCV4 genome, with a 17-bp iterative sequence forming the stem and three non-tandem hexamer motifs (H1/H2: 12-CGGCACACTTCGGCAC-27) identified as the minimal binding site for the Rep protein [6]. This structural feature is highly conserved among circoviruses and underscores the functional similarity of PCV4 to its congeners despite their genetic divergence.

Genetic Diversity and Classification into Genotypes

The expanding repository of PCV4 complete genome sequences, now numbering well over 60 strains from diverse geographic regions and host species, has enabled a robust genotypic classification system. Early phylogenetic studies based on a limited number of strains initially proposed two major genotypes, designated PCV4a and PCV4b, with the prototypical Hunan strain HNU-AHG1-2019 serving as the reference for PCV4a [5, 12]. However, subsequent analyses incorporating a broader sampling of strains from pigs, dairy cows, dogs, cats, and fur animals have refined this classification to include a third genotype, PCV4c, which is supported by both nucleotide phylogeny and distinct amino acid signatures in the Rep and Cap proteins [2, 4, 7]. Specifically, genotype-specific molecular markers have been identified: a valine-to-leucine substitution at position 239 (V239L) in the Rep protein, and three amino acid variations in the Cap protein, asparagine-to-serine at position 27 (N27S), arginine-to-glycine at position 28 (R28G), and methionine-to-leucine at position 212 (M212L) [2, 7]. These markers are highly conserved within each genotype and provide a reliable means for genotyping by sequencing or, potentially, by type-specific PCR assays. The PCV4c genotype, which includes strains such as SC-GA2022ABTC from Sichuan, China, and several strains from dairy cows and dogs, appears to be phylogenetically basal to PCV4a and PCV4b, suggesting it may represent the ancestral lineage from which the other two genotypes arose [2, 4]. Notably, the high nucleotide identity (97.5–99.7%) among all PCV4 strains sequenced to date, irrespective of genotype, geographic origin, or host species, indicates a relatively slow evolutionary rate and a recent common ancestor, consistent with retrospective detection of PCV4 in archival samples dating back to 2012 [2, 4, 5]. This level of conservation is remarkable given the virus's expanding host range and geographic distribution, and it contrasts sharply with the substantial genetic drift observed in PCV2 and PCV3 over similar timeframes [9, 10].

Cross-Species Transmission and Expanding Host Range

One of the most significant revelations in PCV4 research has been the demonstration of its ability to infect multiple non-porcine hosts, challenging the traditional paradigm of circovirus host specificity. Following the initial detection in pigs, PCV4 DNA was identified in fecal samples from dairy cows (Bos taurus) in Henan Province, China, with a positivity rate of 2.22% (26/1170) across samples collected between 2012 and 2021 [2]. Phylogenetic analysis of three complete genomes obtained from bovine-origin strains (NY2012-DC, XC2013-DC, and a 2021 strain) revealed high sequence identity (97.5–99.5%) with porcine reference strains, and importantly, the detection of PCV4 in samples from 2012 and 2013 indicates that the virus has been circulating in dairy cattle for at least a decade prior to its first description in swine [2]. Subsequent investigations extended the host range to domestic dogs (Canis lupus familiaris), with PCV4 DNA detected in 5.99% (13/217) of fecal samples from diarrheic dogs in Henan Province, and in 1.14% (3/264) of samples from animal hospitals in southwestern China [7, 8]. The complete genome of a canine PCV4 strain (HN-Dog) shared 97.9–99.6% nucleotide identity with reference strains and clustered within the PCV4b genotype, further supporting the concept of facile cross-species transmission [7]. Most recently, PCV4 was detected in cats (Felis catus), with a positive rate of 4.31% (5/116) in samples from Sichuan Province, China, and the complete genome of one feline strain (SCGA-Cat) exhibited 98.2–99.0% identity to strains from pigs, dogs, dairy cows, and fur animals such as raccoon dogs and foxes [3]. These findings collectively establish PCV4 as a multi-host pathogen with a remarkably broad host range that includes at least six mammalian orders within the Artiodactyla and Carnivora. The ability of PCV4 to infect and replicate in such phylogenetically diverse hosts is unprecedented among circoviruses and raises important questions about the mechanisms of viral entry, cellular tropism, and immune evasion that facilitate this cross-species transmission. The World Organisation for Animal Health (WOAH) has recognized the potential implications of this emerging virus for both animal health and, given the close contact between humans and companion animals, possibly for public health surveillance, although no evidence of human infection has been reported to date.

Epidemiological Significance and Diagnostic Considerations

The global epidemiological landscape of PCV4 is still emerging, but available data point to a widespread distribution across China and South Korea, with detection rates varying considerably depending on geographic region, sample type, and clinical presentation. In pigs, PCV4 positivity rates have ranged from 1.34% in southwestern China to as high as 33.08% in eastern Chinese provinces, with co-infection rates with PCV2 and PCV3 exceeding 30% in some studies [4, 11, 12]. The virus has been detected in clinically healthy animals as well as in pigs exhibiting respiratory disease, enteric signs, reproductive failure, and PDNS-like lesions, suggesting either that PCV4 can cause a spectrum of clinical syndromes or that it frequently acts as a co-factor in polymicrobial disease complexes [5, 6]. The high prevalence of PCV4 in samples from pigs co-infected with porcine reproductive and respiratory syndrome virus (PRRSV), PCV2, and other pathogens complicates the attribution of specific pathology to PCV4 alone, and experimental inoculation studies are urgently needed to fulfill Koch's postulates [6, 12]. The development of sensitive and specific diagnostic tools has been critical for advancing PCV4 research. Real-time quantitative PCR (qPCR) assays targeting the ORF2 gene, including TaqMan-based and SYBR Green-based platforms, have been established with detection limits as low as 2.2 × 10¹ DNA copies per reaction and amplification efficiencies approaching 100% [1, 6]. Multiplex qPCR assays capable of simultaneously detecting PCV2, PCV3, and PCV4 have been validated for clinical use, revealing that triple infections occur in nearly 30% of suspected PCV-associated disease cases in some regions [11]. More recently, recombinase-aided amplification (RAA) assays have been developed for rapid, isothermal detection of PCV3 and PCV4, with results obtainable within 20 minutes at 39°C, making them suitable for point-of-care or field-based surveillance [13]. These molecular tools, combined with retrospective serological surveys and next-generation sequencing approaches, will be essential for establishing the true global prevalence, transmission dynamics, and clinical impact of PCV4. The retrospective detection of PCV4 in bovine samples from 2012 and in porcine samples from 2018 underscores the need for systematic archival sample screening to determine the historical origins and evolutionary trajectory of this emerging pathogen [2, 5]. As PCV4 continues to be identified in new geographic regions and host species, coordinated surveillance efforts under the auspices of organizations such as the Food and Agriculture Organization (FAO) and WOAH will be crucial for monitoring its spread and for informing risk assessment and control strategies.

Genomic Organization and Phylogenetic Analysis of PCV4

The genomic architecture of Porcine circovirus 4 (PCV4) represents a paradigmatic example of the minimalistic genetic strategy employed by members of the genus Circovirus within the family Circoviridae. As a recently emerged pathogen first identified in 2019 from a herd of pigs exhibiting porcine respiratory disease and dermatitis and nephropathy syndrome in Hunan Province, China [1, 5], PCV4 possesses a circular, single-stranded DNA genome of approximately 1,770 nucleotides in length [1, 6]. This compact genome size is consistent with that of other circoviruses, yet it harbors distinct genetic features that underpin its unique pathogenic potential and evolutionary trajectory. The complete genomic sequences of numerous PCV4 strains have now been elucidated from diverse host species and geographical regions, revealing a highly conserved genomic organization that belies a surprising degree of phylogenetic complexity and ongoing evolutionary diversification.

2.1. Genome Architecture and Functional Elements

The PCV4 genome, like that of its congeneric relatives PCV1, PCV2, and PCV3, is organized in an ambisense manner, encoding two major open reading frames (ORFs) that are oriented in opposite directions. ORF1, located on the complementary strand, encodes the replicase (Rep) protein, a multifunctional enzyme essential for rolling-circle replication of the viral genome. ORF2, situated on the virion strand, encodes the capsid (Cap) protein, the sole structural component of the viral particle and the primary target of the host immune response. The intergenic region between the 5' ends of these two ORFs contains the origin of replication (Ori), a critical regulatory element that includes a conserved stem-loop structure and iterative sequence motifs essential for Rep binding and initiation of replication [6].

Detailed sequence analysis of the PCV4 genome has revealed that the stem-loop structure, a hallmark of circovirus replication origins, is predicted to form a stable hairpin with a 17-base pair (bp) stem [6]. Within this stem, a specific sequence, identified as H1/H2 (12-CGGCACACTTCGGCAC-27), serves as the minimal binding site for the Rep protein. Downstream of this stem-loop, three non-tandem hexamer motifs have been identified, which are believed to function as iterons, repetitive sequences that facilitate the specific recognition and nicking of the origin by the Rep protein during the initiation of replication [6]. The precise conservation of these elements across PCV4 strains underscores their indispensable role in viral genome replication and provides a molecular basis for understanding the virus's replication strategy.

Comparative genomic analyses have demonstrated that the PCV4 genome shares a high degree of nucleotide identity with other PCV4 strains, typically ranging from 97.5% to 99.7% [2, 4, 6]. However, this level of conservation is not uniform across the genome. The ORF2 (Cap) gene exhibits a higher degree of genetic variability compared to the ORF1 (Rep) gene, a pattern commonly observed in circoviruses and attributed to the selective pressure exerted by the host immune system on the capsid protein. This variability is particularly pronounced in specific regions of the Cap protein, which are likely exposed on the virion surface and are thus targets for neutralizing antibodies. Conversely, the Rep protein, which functions intracellularly, is under stronger functional constraints, leading to greater sequence conservation. The 5' and 3' intergenic regions, while short, also contain conserved elements critical for replication and transcription, including promoter and polyadenylation signals.

2.2. Phylogenetic Classification and Genotype Delineation

Phylogenetic analysis of complete PCV4 genome sequences, as well as individual ORF1 and ORF2 sequences, has consistently supported the classification of PCV4 strains into three distinct genotypes, provisionally designated as PCV4a, PCV4b, and PCV4c [2, 4, 7]. This tripartite genotype structure was initially proposed based on the analysis of 44 PCV4 strains [2] and has been subsequently corroborated by independent studies involving larger datasets of global PCV4 sequences [3, 7]. The phylogenetic clustering is robust and is supported by high bootstrap values in maximum-likelihood and neighbor-joining trees constructed from complete genome alignments.

The delineation of these genotypes is not merely a statistical artifact but is underpinned by specific, conserved amino acid signatures in both the Rep and Cap proteins. These molecular markers provide a reliable and biologically meaningful basis for genotype assignment. Specifically, a single amino acid substitution in the Rep protein, valine to leucine at position 239 (V239L), is a conserved marker for the PCV4b genotype [2, 7]. In the Cap protein, three amino acid variations, asparagine to serine at position 27 (N27S), arginine to glycine at position 28 (R28G), and methionine to leucine at position 212 (M212L), are consistently associated with the PCV4b genotype [2, 7]. Conversely, the PCV4c genotype is characterized by a distinct amino acid pattern: valine at position 239 (239V) in Rep, and asparagine at position 27 (27N), arginine at position 28 (28R), and methionine at position 212 (212M) in Cap [4]. These genotype-specific markers have been validated across multiple studies and are now considered definitive for classifying PCV4 strains.

The geographic and host distribution of these genotypes is an area of active investigation. PCV4a appears to be the most widely distributed genotype, having been identified in pigs, dairy cows, dogs, and cats across multiple provinces in China [2, 3, 7, 12]. PCV4b has been detected in a diverse range of hosts, including pigs, dairy cows, dogs, foxes, and raccoon dogs, suggesting a broad host tropism and potential for cross-species transmission [6, 7]. PCV4c, while less frequently reported, has been identified in pigs in the Southwest of China and in a dog from Henan Province [4, 7]. The biological significance of these genotypic differences, particularly in terms of virulence, host range, and antigenicity, remains to be fully elucidated. However, the identification of conserved amino acid changes in the Cap protein, which is the primary target of the host immune response, raises the possibility that different genotypes may exhibit differential antigenic properties, which could have implications for vaccine development and serological diagnostics.

2.3. Evolutionary Dynamics and Cross-Species Transmission

The evolutionary history of PCV4 is characterized by a relatively slow evolutionary rate, a feature common to single-stranded DNA viruses due to the proofreading activity of host cell DNA polymerases. This slow rate is reflected in the high nucleotide homology observed among PCV4 strains across different temporal, geographical, and host species boundaries [2]. Retrospective studies have been instrumental in tracing the origins of PCV4. The detection of PCV4 DNA in fecal samples from dairy cows collected in Henan Province, China, as early as 2012 and 2013 [2] indicates that PCV4 has been circulating in animal populations for at least a decade before its initial discovery in pigs in 2019. This finding suggests that PCV4 is not a truly novel virus but rather an emerging pathogen that has recently come to clinical attention, possibly due to changes in host susceptibility, viral virulence, or increased surveillance efforts.

The detection of PCV4 in a wide range of non-porcine hosts, including dairy cows [2], dogs [7, 8], cats [3], foxes, and raccoon dogs [6], underscores its remarkable capacity for cross-species transmission. This is a significant finding from both an epidemiological and a public health perspective. The close phylogenetic clustering of PCV4 strains from different host species, often with high nucleotide identity (>98%), suggests that cross-species transmission events are relatively frequent and that the virus can readily adapt to new hosts without requiring extensive genetic change [2, 3, 7]. For instance, the PCV4 strain SCGA-Cat, isolated from a cat in Sichuan Province, China, clustered closely with a PCV4 strain derived from a pig in Fujian Province, demonstrating direct or indirect transmission between these two species [3]. Similarly, the dog-origin strain HN-Dog was found to be closely related to strains from pigs, raccoon dogs, and foxes [7]. These observations challenge the traditional view of PCV4 as a strictly porcine pathogen and highlight the potential for the virus to establish itself in new ecological niches.

The mechanisms driving this cross-species transmission are not fully understood but likely involve direct or indirect contact between infected and susceptible animals. Pigs, as the primary reservoir, may shed the virus in feces, respiratory secretions, and other bodily fluids, contaminating the environment and facilitating transmission to other species sharing the same habitat, such as dogs, cats, and livestock [2, 3, 7]. The role of fomites and vectors in this process cannot be discounted. The ability of PCV4 to infect such a diverse array of mammalian hosts raises important questions about its potential to infect humans. While no cases of human PCV4 infection have been reported to date, the precedent set by other circoviruses, such as PCV1 and PCV2, which have been detected as adventitious agents in human vaccines [14], warrants continued vigilance. The World Health Organization (WHO) and the World Organisation for Animal Health (WOAH) have emphasized the importance of monitoring emerging zoonotic pathogens, and PCV4's expanding host range makes it a candidate for such surveillance.

2.4. Recombination and Genetic Diversity

Recombination is a major driving force in the evolution of circoviruses, contributing to the generation of genetic diversity and the emergence of novel strains with altered pathogenic potential. Although recombination events have been more extensively documented in PCV2 [12], evidence suggests that PCV4 is also subject to this evolutionary mechanism. The identification of putative recombination events in PCV4 strains, particularly within the ORF2 gene, indicates that the viral genome can undergo genetic exchange, potentially leading to the emergence of new genotypes or variants with distinct biological properties [12]. The presence of multiple genotypes (PCV4a, PCV4b, PCV4c) may, in part, be a consequence of historical recombination events, although the precise contribution of recombination versus mutation to the observed genetic diversity remains to be quantified.

The genetic diversity of PCV4, while lower than that of PCV2, is not insignificant. The amino acid variations observed in the Cap protein, particularly at positions 27, 28, and 212, are located in regions that may influence antigenicity and receptor binding. Changes in these residues could alter the virus's ability to evade the host immune response or to infect different cell types, thereby affecting its tropism and pathogenicity. The ongoing surveillance of PCV4 genetic diversity, as recommended by the WOAH, is crucial for monitoring the emergence of potentially more virulent or vaccine-resistant strains. The development of robust phylogenetic frameworks, such as the PCV4a/PCV4b/PCV4c classification system, provides a valuable tool for tracking the spatiotemporal spread of different viral lineages and for assessing the impact of genetic changes on viral fitness.

In conclusion, the genomic organization of PCV4 is a masterpiece of genetic economy, encoding essential replication and structural proteins within a remarkably small circular DNA genome. The phylogenetic analysis of global PCV4 strains has revealed a structured population consisting of three major genotypes, each defined by specific molecular markers in the Rep and Cap proteins. The virus's ability to infect a wide range of mammalian hosts, coupled with its relatively slow evolutionary rate and capacity for recombination, paints a picture of a successful emerging pathogen that is well-adapted for cross-species transmission. Continued genomic surveillance, guided by the principles of One Health and supported by international bodies such as the WOAH and the FAO, will be essential for understanding the evolutionary trajectory of PCV4 and for mitigating its potential impact on animal health and, possibly, public health.

Molecular Pathogenesis and Host Immune Response

Genomic Architecture and Key Open Reading Frames

The molecular pathogenesis of porcine circovirus 4 (PCV4) is inextricably linked to its compact genomic structure and the functional properties of its encoded proteins. The PCV4 genome is a single-stranded, circular DNA molecule of approximately 1,770 nucleotides, making it one of the smallest known autonomously replicating viral genomes [1, 6]. This minimalistic genetic organization encodes two principal open reading frames (ORFs): ORF1, which produces the replicase (Rep) protein essential for rolling-circle replication, and ORF2, which encodes the capsid (Cap) protein responsible for virion assembly and host cell receptor binding [1, 6, 12]. The virus lacks a DNA polymerase, forcing it to rely entirely on the host cell’s replication machinery and the Rep protein’s site-specific endonuclease and ligase activities to initiate and complete genome replication.

The Rep protein of PCV4, like those of other circoviruses, contains conserved motifs associated with rolling-circle replication, including a dNTP-binding domain (Walker A and B motifs) and a HUH endonuclease domain [6]. Comparative genomic analyses have revealed that PCV4 Rep exhibits a unique amino acid signature that distinguishes it from other porcine circovirus species. Specifically, a valine-to-leucine substitution at position 239 (V239L) in the Rep protein serves as a conserved genotype-specific molecular marker, differentiating PCV4b and PCV4c strains from PCV4a [2, 4, 7]. This polymorphism may have functional consequences for viral replication efficiency, as it lies within a region potentially involved in protein-protein interactions or DNA binding. The Cap protein, which forms the icosahedral capsid and mediates attachment to host cell receptors, displays three consistent amino acid variations (N27S, R28G, and M212L) that define distinct genotypes [2, 7]. These residues are located on the surface-exposed loops of the capsid, suggesting they may influence antigenicity, receptor tropism, and susceptibility to neutralizing antibodies.

The intergenic region of PCV4 contains a putative stem-loop structure critical for the initiation of rolling-circle replication [6]. This structure includes a nonamer sequence that serves as the origin of replication, flanked by inverted repeats that form the stem. Importantly, Chen et al. (2023) identified a 17-bp iterative sequence predicted to form the stem structure, within which three non-tandem hexamers were found downstream, with the sequence 12-CGGCACACTTCGGCAC-27 representing the minimal binding site for Rep [6]. The precise spacing and sequence conservation of these elements are essential for efficient origin recognition and nicking by the Rep protein. Disruption of this stem-loop through mutation would likely abrogate viral replication, underscoring its centrality to the PCV4 life cycle.

The Replication Cycle and Viral DNA Synthesis

The replication cycle of PCV4 is poorly understood at the cellular level, but parallels can be drawn from the well-characterized PCV2 replication model. Upon entry into susceptible host cells, likely through clathrin-mediated endocytosis, the virus uncoats and releases its single-stranded DNA genome into the nucleus. The complementary strand is synthesized by host DNA polymerases to generate a double-stranded replicative form, which serves as the template for transcription and further replication [6, 12]. The Rep protein binds to the stem-loop origin, nicks the positive strand, and initiates rolling-circle replication, producing concatemeric double-stranded intermediates that are subsequently cleaved and circularized into progeny genomes.

One of the most intriguing aspects of PCV4 replication is its apparent dependence on cellular factors that are modulated by the metabolic state of the host. Drawing from PCV2 research, glutamine availability and intracellular glutathione levels have been shown to significantly impact circovirus replication. Chen et al. (2015) demonstrated that glutamine starvation significantly enhanced PCV2 replication in PK-15 cells, an effect mediated by increased phosphorylation of p38 mitogen-activated protein kinase (MAPK) [18]. This pathway was activated in response to reduced intracellular glutathione levels, a consequence of glutamine deprivation. The authors showed that adding buthionine sulfoximine, a glutathione synthesis inhibitor, similarly promoted viral replication, while p38 knockdown completely abrogated the replication-enhancing effect [18]. By analogy, PCV4 replication may be similarly influenced by cellular stress responses and redox status, suggesting that nutritional status and oxidative stress in pigs could modulate susceptibility to PCV4 infection and disease progression. The p38 MAPK pathway is a central regulator of pro-inflammatory cytokine production, and its activation during viral replication may represent a double-edged sword: necessary for optimal viral replication but also contributing to immunopathology.

Molecular Determinants of Cross-Species Transmission

A striking feature of PCV4, which sets it apart from PCV2 and PCV3, is its surprisingly broad host range. Since its initial detection in pigs in 2019, PCV4 DNA has been molecularly identified in dairy cows [2], dogs [7, 8], cats [3], and fur animals including raccoon dogs and foxes [6]. This cross-species transmission suggests that the PCV4 capsid protein possesses a high degree of plasticity in receptor recognition, enabling it to bind to entry receptors on cells of diverse mammalian species. The amino acid substitutions N27S, R28G, and M212L, which define the PCV4b and PCV4c genotypes, are located on the surface of the capsid and may influence these interactions [2, 7]. Molecular modeling studies of PCV2 have identified a receptor-binding domain in the capsid that interacts with heparan sulfate glycosaminoglycans and an unidentified proteinaceous receptor. It is plausible that PCV4 uses similar attachment factors, but the specific residues mediating these interactions remain to be experimentally determined.

The detection of PCV4 in dairy cows as early as 2012, seven years before its formal discovery in pigs, indicates that the virus has been circulating undetected in non-porcine hosts for at least a decade [2]. The high nucleotide identity (97.5–99.5%) between bovine and porcine PCV4 strains suggests a recent cross-species transmission event or, more likely, a slow evolutionary rate consistent with single-stranded DNA viruses that are replicated by host polymerases [2]. Xu et al. (2022) analyzed PCV4 sequences from multiple time points, species, and geographic regions and found remarkably high homology, leading them to conclude that the PCV4 evolutionary rate might be slow [2]. This has important implications for pathogenesis, as a slowly evolving virus may be more constrained in its ability to escape host immune responses, but its broad host range suggests inherent immune evasion capabilities.

In dogs, PCV4 was detected in 5.99% of fecal samples from diarrheic animals, with the complete genome of the HN-Dog strain showing 97.9–99.6% identity to reference strains [7]. Similarly, PCV4 was identified in cats at a rate of 4.31%, and the SCGA-Cat strain clustered closely with a pig-derived strain from Fujian Province, China [3]. The detection of PCV4 in multiple carnivore species raises the possibility of a transmission cycle involving pigs as the primary reservoir and companion animals as accidental or spillover hosts. Whether these species can sustain PCV4 transmission independently or require ongoing introduction from swine populations is unknown. Nevertheless, the molecular evidence firmly establishes that PCV4 is not strictly porcine and that its host range extends across multiple orders within the class Mammalia.

Pathogenesis: Cytopathology and Tissue Tropism

The pathogenesis of PCV4 infection appears to share several features with that of PCV2, but important differences are emerging. PCV4 has been detected in multiple tissue types, including lung, lymph node, spleen, kidney, and intestine, suggesting a broad tissue tropism similar to PCV2 [5, 6, 17]. However, unlike PCV2, which is predominantly associated with lymphoid tissue and causes lymphoid depletion, the primary target cells for PCV4 have not been definitively identified. The detection of PCV4 in fecal samples from multiple species, pigs, dogs, cats, and dairy cows, indicates that the virus replicates in the intestinal epithelium or is shed via the gastrointestinal tract [2, 3, 7, 8]. This enteric tropism may be a distinguishing feature of PCV4 compared to the predominantly respiratory and lymphoid tropism of PCV2 and PCV3.

In pigs, PCV4 has been detected in association with porcine respiratory disease complex (PRDC), dermatitis and nephropathy syndrome (PDNS), and reproductive failure [1, 11]. Tian et al. (2020) detected PCV4 in pigs with various clinical presentations, including respiratory distress and PDNS-like lesions [5]. However, causality has not been firmly established, and the role of PCV4 as a primary pathogen versus a co-factor remains debated. The development of clinical disease likely depends on the presence of co-infections, host immune status, and environmental stressors, a scenario reminiscent of PCV2-associated disease. The fact that PCV4 was found in 25.40% of clinical samples from Henan and Shanxi provinces, with 50% of pig farms positive, underscores its widespread circulation and potential economic impact [5].

Histopathological lesions associated with PCV2 infection include lymphoid depletion, histiocytic infiltration, and inclusion bodies in macrophages [17]. Whether PCV4 induces similar lesions is not yet known, but the detection of PCV4 DNA in lymph nodes and spleen suggests that lymphoid tissues may be sites of viral replication. The ability of circoviruses to persist in lymphoid tissues and cause immunosuppression is a hallmark of PCV2 pathogenesis. If PCV4 similarly targets antigen-presenting cells and disrupts the architecture of lymphoid follicles, it could predispose pigs to secondary bacterial and viral infections, exacerbating clinical disease.

Subversion of the Host Immune Response

The host immune response to PCV4 infection is only beginning to be elucidated, but insights from PCV2 immunology provide a valuable framework. PCV2 is renowned for its ability to evade and subvert the host immune system through multiple mechanisms, including suppression of interferon-alpha production, inhibition of natural killer cell activity, and modulation of cytokine responses [15]. Qi et al. (2019) demonstrated that PCV2 co-infection with Actinobacillus pleuropneumoniae suppressed reactive oxygen species production by inhibiting NADPH oxidase activity, thereby reducing bacterial clearance by porcine alveolar macrophages [15]. During co-infection, PCV2 weakened the inflammatory response and macrophage antigen presentation by decreasing TNF-α, IFN-γ, and IL-4 expression [15]. These findings are directly relevant to understanding PCV4 pathogenesis, as PCV4 is frequently detected in co-infections with other pathogens, including PCV2, PCV3, porcine reproductive and respiratory syndrome virus (PRRSV), and various bacteria [6, 11, 12].

Zou et al. (2022) reported that co-infection rates for PCV4 with PCV2 or PCV3 in East China were 30.09% and 30.84%, respectively, and triple infection with all three PCVs occurred in 28.22% of samples [11]. This extraordinarily high rate of co-infection strongly suggests that PCV4, like PCV2, possesses immune modulatory capabilities that facilitate the establishment and persistence of multiple pathogens. The molecular basis for this synergy likely involves the inhibition of key innate immune pathways. The p38 MAPK pathway, which was shown to be critical for PCV2 replication [18], is also a central regulator of pro-inflammatory cytokine production. PCV4 may similarly manipulate this signaling node to create an intracellular environment permissive for replication while suppressing antiviral responses.

The capsid protein of circoviruses is the primary target of the host humoral immune response, and neutralizing antibodies are directed against conformational epitopes on the capsid surface. The amino acid variations at positions 27, 28, and 212 in the PCV4 Cap protein, which define the different genotypes, may represent antigenic drift that allows the virus to evade neutralizing antibodies [2, 7]. Molecular modeling of the PCV3 capsid has identified mutations within predicted T-cell epitopes, such as the F104Y mutation lying within a predicted T-cell epitope [9]. By analogy, the PCV4 cap may contain similarly positioned epitopes that are under selective pressure from the host immune system. The identification of three distinct genotypes (PCV4a, PCV4b, and PCV4c) based on these amino acid markers suggests that antigenic variation is a continuing process in the field [2, 4, 7].

Implications for Viral Persistence and Co-infection Syndromes

The ability of PCV4 to establish persistent infections and its frequent association with other pathogens raises important questions about its role in the porcine respiratory disease complex and other multifactorial diseases. In a study by Chen et al. (2023), PCV4 was detected in 8.00% of clinical samples from Shaanxi and Henan provinces, with a notable co-infection case involving PRRSV in the lung tissue of a suckling pig with respiratory symptoms [6]. The authors sequenced five complete PCV4 genomes from these cases, demonstrating that co-circulating strains belong to multiple genotypes [6]. The synergistic interaction between PCV2 and PRRSV is well-documented, with PRRSV-induced immunosuppression exacerbating PCV2 replication and disease. A similar relationship may exist between PCV4 and PRRSV, as both viruses target macrophages and modulate the host immune response.

Porcine parvoviruses have also been implicated as co-factors in PCV2-associated disease. Tregaskis et al. (2020) found a statistically significant clustering co-factor association between novel porcine parvovirus 2 (PPV2) and PCV2 in pigs with PRDC and PCV-associated disease [16]. Given that PCV4 has been detected in similar clinical contexts, it is plausible that PPV2 and other parvoviruses may also serve as co-factors for PCV4 pathogenesis. The molecular mechanisms driving these interactions are likely complex, involving both direct effects on target cells and indirect effects on the immune system. For example, parvoviruses can induce cell cycle arrest and DNA damage responses that may enhance circovirus replication, while circovirus-induced immune suppression may permit parvovirus dissemination.

The detection of PCV4 in dairy cows, a species not previously considered a host for porcine circoviruses, raises concerns about the potential for PCV4 to serve as a vector for genetic recombination with other circoviruses. Co-infection of a single animal with PCV2, PCV3, and PCV4 could theoretically lead to recombination events that generate novel viruses with altered host range or virulence. Although PCV4 has not been detected in cattle in the Netherlands [19] or elsewhere outside China and South Korea, the retrospective detection in Chinese dairy cows [2] indicates that surveillance efforts should be expanded globally. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) should consider including PCV4 in their list of emerging swine pathogens and support coordinated international surveillance programs.

Summary of Pathogenic Mechanisms and Unanswered Questions

The molecular pathogenesis of PCV4 is a story still being written, but the available data point to a virus that is adept at crossing species barriers, establishing persistent infections, and synergizing with other pathogens to cause clinical disease. The Rep and Cap proteins, with their genotype-defining amino acid variations, are central to these processes. The capsid’s ability to recognize receptors on cells of multiple mammalian species is remarkable and warrants urgent structural studies to define the receptor-binding interface. The virus’s reliance on the p38 MAPK pathway and its sensitivity to cellular redox status provide potential targets for antiviral intervention, but whether these pathways are exploited by PCV4 itself remains to be tested directly.

The host immune response to PCV4 appears to be insufficient to clear the infection in many cases, as evidenced by viral persistence in the face of detectable antibodies. The mechanisms of immune evasion, whether through downregulation of MHC expression, inhibition of interferon signaling, or modulation of cytokine networks, have not been studied for PCV4 but are likely similar to those employed by PCV2. The high rates of co-infection with PCV2, PCV3, and PRRSV suggest that PCV4 may act as an immunosuppressive co-factor, tipping the balance toward clinical disease in herds that are already compromised.

Critical gaps in our understanding include the identity of the cellular receptor for PCV4, the kinetics of viral replication in different tissues, and the role of the capsid’s surface-exposed loops in antigenicity and neutralization. Animal experiments using specific-pathogen-free piglets inoculated with PCV4 are urgently needed to fulfill Koch’s postulates and define the pathology attributable to PCV4 alone, as opposed to co-infections. The discovery of PCV4 in dogs, cats, and dairy cows also necessitates studies to determine whether these species can transmit the virus back to pigs or to humans. While there is no evidence that PCV4 infects humans, the precedent of PCV1 contamination of rotavirus vaccines [14] underscores the need for vigilance in the production of porcine-derived biological products.

Epidemiology and Global Distribution of PCV4

The emergence of Porcine circovirus 4 (PCV4) represents a significant new chapter in the understanding of circovirus ecology and swine infectious disease. First identified in 2019 from a herd of pigs exhibiting porcine respiratory disease complex (PRDC) and porcine dermatitis and nephropathy syndrome (PDNS) in Hunan Province, China [1, 5], PCV4 has rapidly transitioned from a novel isolate to a virus of substantial epidemiological concern. Its detection across multiple provinces in China, in South Korea, and in an expanding range of non-porcine hosts, including dairy cattle, dogs, cats, and fur animals, has fundamentally altered the perception of this pathogen's ecological niche and its potential for global dissemination [1-3, 7]. This section provides an exhaustive analysis of the current epidemiological landscape, phylogenetic architecture, and spatial-temporal dynamics of PCV4, drawing primarily from the foundational surveillance studies conducted across China and the Korean Peninsula since 2019.

Discovery and Initial Characterization in Swine

The index identification of PCV4 was made during an investigation of severe clinical disease in swine in Hunan Province in 2019 [5]. The initial strain, designated HNU-AHG1-2019, was isolated from pigs with concurrent respiratory signs and PDNS-like lesions. This discovery immediately prompted retrospective and prospective surveillance efforts across central and eastern China. A pivotal early study by Tian et al. (2020) screened 63 clinical samples from 24 distinct pig farms across 14 cities in Henan and Shanxi Provinces, collecting samples between February 2018 and December 2019 [5]. This work demonstrated a startling prevalence: 25.40% (16/63) of individual samples were PCR-positive for PCV4, and critically, 50% (12/24) of the surveyed farms harbored the virus [5]. This finding established that PCV4 was not a sporadic or isolated agent but was already widely circulating within major swine-producing regions of China prior to its formal discovery. The Henan-LY1-2019 strain sequenced from this survey shared 98.4% genomic nucleotide identity with the Hunan index strain, confirming a close genetic relationship and suggesting a common ancestor was actively propagating across provincial boundaries [5].

Subsequent investigations have refined our understanding of PCV4 prevalence in swine, revealing a highly variable detection rate that appears to be influenced by geographic region, sample type, clinical status of the animals, and the diagnostic assay employed. A large-scale multiplex qPCR survey of 535 clinical samples from East China (Shandong, Zhejiang, Jiangsu, and Anhui provinces) conducted between 2020 and 2022 yielded a startling individual PCV4-positive rate of 33.08% [11]. The mixed infection rates were equally concerning: PCV2 and PCV4 co-infection was detected in 30.09% of samples, PCV3 and PCV4 co-infection in 30.84%, and triple co-infection with PCV2, PCV3, and PCV4 was identified in 28.22% of all tested samples [11]. This highlights a complex epidemiological reality where PCV4 circulates within a co-infection milieu alongside other established circoviruses, a phenomenon that complicates diagnosis and may potentiate disease severity through synergistic pathogenesis.

In Henan Province, a duplex qPCR assay targeting both PCV2 and PCV4 applied to 133 clinical samples (103 tissue and 30 serum samples) from 30 different farms found a PCV4-positive rate of 33.33% (45/133) and a PCV2/PCV4 co-infection rate of 21.05% (28/133) [12]. A separate study in Shaanxi and Henan Provinces focusing on 150 samples from nine swine farms detected PCV4 in 8.00% (12/150) of samples, with a notable case of PCV4 and PRRSV co-infection identified in the lung tissue of a suckling pig with respiratory symptoms [6]. This detection of co-infection with PRRSV, a globally significant immunosuppressive pathogen, raises critical questions about the role of PCV4 as a secondary or opportunistic agent within the porcine respiratory disease complex (PRDC) [20].

Conversely, surveys in the Southwest of China, specifically in Sichuan Province, have reported substantially lower prevalence rates. Chen et al. (2022) tested 67 clinical samples (blood, tissue, saliva swabs, and semen) from Sichuan pig farms using a highly sensitive TaqMan real-time PCR and found only 3 positive samples (4.48%) [1]. Similarly, Xu et al. (2022) screened 374 samples from diseased pigs across 12 cities in Southwest China during 2021-2022 and detected PCV4 in only 1.34% (5/374) of samples, with the virus confined to just two of the surveyed cities [4]. This geographic disparity, high prevalence in East and Central China versus low prevalence in the Southwest, may reflect differences in farming density, biosecurity practices, or the timing of viral introduction. The most recent prevalence data from Xinjiang Province in Northwest China (2022-2024) reported a PCV4-positive rate of 17% among 453 deceased pigs, alongside co-infection rates of 15% for PCV1, 71% for PCV2, and 25% for PCV3 [10]. This wide variance, from 1.34% to 33.33% in swine, underscores the critical need for standardized, large-scale surveillance protocols to accurately estimate the true continental prevalence.

Expansion of Viral Host Range: Cross-Species Transmission

Perhaps the most alarming epidemiological development regarding PCV4 has been the repeated demonstration of its ability to infect non-porcine hosts. This cross-species transmission potential distinguishes PCV4 from PCV2 and PCV3 and suggests a broader ecological host range with implications for viral maintenance and spillback into swine populations.

Dairy Cattle: The first evidence of PCV4 in a non-porcine species was provided by Xu et al. (2022), who conducted a retrospective molecular investigation of fecal samples from dairy cows in Henan Province, China, spanning a decade (2012-2021) [2]. Among 1,170 fecal samples collected from dairy farms across seven cities, 2.22% (26/1170) were positive for PCV4 by qPCR. Remarkably, the same samples were uniformly negative for PCV2 and PCV3, suggesting PCV4 may have a unique capacity to replicate or persist in bovine hosts [2]. Even more striking was the acquisition of two PCV4 strains (NY2012-DC and XC2013-DC) from samples collected in 2012 and 2013, respectively. This provides definitive molecular evidence that PCV4 has been circulating in dairy cows in China for at least a decade prior to its first reported detection in swine in 2019 [2]. This finding has profound epidemiological implications: dairy cattle may represent a historical or even a reservoir host, with PCV4 potentially having originated or maintained itself in a bovine reservoir before spilling over into swine populations. The three full-length PCV4 genomes obtained from these bovine samples shared 97.5-99.5% identity with swine-derived reference strains, indicating a high degree of genetic conservation across species [2].

Dogs: Two independent research groups simultaneously reported the first detection of PCV4 in dogs in 2023. Zhang et al. (2023) analyzed 217 fecal samples from diarrheic dogs in Henan Province, detecting an overall positivity rate of 5.99% (13/217), with annual rates of 7.44% in 2020 and 4.17% in 2021 [7]. The virus was present in dogs from 6 out of 10 surveyed cities, demonstrating a wide geographic distribution within the province. The complete genome of the HN-Dog strain exhibited 97.9-99.6% identity with reference strains from pigs, raccoon dogs, and foxes [7]. Concurrently, Xu et al. (2023) screened 264 dog samples from animal hospitals in Southwest China (Sichuan Province) and found a lower prevalence of 1.14% (3/264), with the SCABTC-Dog2022 strain sharing 97.9-99.0% identity with other PCV4 strains [8]. The association between PCV4 detection and clinical diarrhea in dogs remains correlative rather than causative; controlled pathogenesis studies are urgently needed to determine if PCV4 is a primary enteric pathogen in canines or an incidental bystander.

Cats: Xu et al. (2023) expanded the host range further by detecting PCV4 in 5 out of 116 clinical samples (4.31%) collected from cats in Sichuan Province, China, between 2021 and 2022 [3]. This represents the first global report of PCV4 in felines. The complete genome of the SCGA-Cat strain revealed 98.2-99.0% nucleotide homology with PCV4 strains from other species, and phylogenetic analysis placed it in a cluster with a pig-derived strain from Fujian Province [3]. The detection of PCV4 in both dogs and cats, animals that share indoor environments and close contact with humans, raises a critical but currently unanswered question regarding zoonotic potential. While no evidence currently links PCV4 to human disease, the precedent of PCV1 and PCV2 contamination of human vaccines and porcine-derived medical products (e.g., heparin, as investigated for PCV2) warrants ongoing serosurveillance in human populations, particularly among immunocompromised individuals [14, 21].

Fur Animals and Other Mammals: The host range of PCV4 extends to farmed fur animals as well. A study in Shaanxi Province detected PCV4 in samples from foxes and raccoon dogs, with phylogenetic analyses clustering these strains alongside those from pigs, dairy cows, and dogs [6, 7]. This suggests that PCV4 is circulating within the broader mammalian ecosystem of agricultural and peri-domestic environments. The ability of a single-stranded DNA virus to infect such a phylogenetically diverse array of hosts (Suidae, Bovidae, Canidae, Felidae, and Mustelidae) is remarkable and suggests that the viral receptor or entry mechanism is highly conserved across mammalian species.

Genotypic Diversity and Phylogeography

The rapid accumulation of PCV4 genomic sequences has enabled a robust phylogenetic classification of the virus into three distinct genotypes: PCV4a, PCV4b, and PCV4c [2, 4, 7]. This genotypic framework is supported by specific, conserved amino acid markers. The Rep protein exhibits a key variation at position 239 (V239L), while the Cap protein shows three signature variations at positions 27 (N27S), 28 (R28G), and 212 (M212L) [2, 7]. These markers are considered genotype-specific and provide a molecular basis for tracking the spatiotemporal evolution of the virus.

The PCV4c genotype, to which many of the more recently sequenced strains belong (e.g., SC-GA2022ABTC from Sichuan), is characterized by a specific amino acid pattern of 239V in Rep and 27N, 28R, and 212M in Cap [4]. The PCV4a genotype appears to have been more prevalent in earlier surveys, such as the 2018-2019 samples from Henan [5, 12]. Xu et al. (2021) classified their six Henan-derived PCV4 strains as belonging to PCV4a, while the global collection of 35 strains clustered into the two major genotypes PCV4a and PCV4b [12]. The most recent phylogenetic analyses incorporating 42 to 60 strains have consistently confirmed the presence of the three-genotype model [4, 7].

Crucially, evolutionary analysis suggests that the rate of nucleotide substitution in PCV4 is relatively slow. This inference is drawn from three independent lines of evidence: (1) high sequence identity across time, as demonstrated by the 2012-2013 bovine strains being nearly identical to 2019-2022 strains; (2) high identity across species (pig, cow, dog, cat, fox strains sharing >97.5% identity); and (3) high identity across international borders (Chinese and South Korean strains showing minimal divergence) [2]. This slow evolutionary rate is typical of single-stranded DNA viruses but contrasts with the rapid evolution seen in some RNA viruses. It implies that PCV4 may have been circulating in an endemic, stable state for many years before its recognition, and that any future emergence of highly pathogenic variants may require recombination events rather than gradual mutation.

The spatial distribution of PCV4 within China reveals a patchwork pattern. Detection has been confirmed in at least 11 provinces: Hunan, Henan, Shanxi, Shaanxi, Sichuan, Fujian, Jiangsu, Zhejiang, Anhui, Shandong, and Xinjiang [1, 4-6, 10-12]. Phylogenetic trees often show a geographical clustering, with strains from Sichuan grouping with those from Fujian, Hunan, and Inner Mongolia [8]. This suggests that movement of pigs, contaminated fomites, or even wildlife may be facilitating the inter-provincial spread of specific viral clades.

Global Status and Surveillance Gaps

At present, published peer-reviewed evidence of PCV4 outside of China is limited to South Korea [1]. However, given the global nature of swine trade and the prevalence of PCV4 in Chinese swine herds, it is highly probable that the virus has been disseminated internationally. The absence of reports from Europe, the Americas, or other parts of Asia may reflect a genuine absence or, more likely, a lack of targeted surveillance. Most diagnostic laboratories in North America and Europe do not routinely test for PCV4; the commonly used multiplex PCR panels for circoviruses are designed for PCV1, PCV2, and PCV3 [13]. With the development and validation of highly sensitive and rapid detection assays, including TaqMan PCR, SYBR Green qPCR, and recombinase-aided amplification (RAA) assays that can detect PCV4 alongside PCV3 [1, 6, 13], the technical barriers to large-scale global surveillance have been removed. The World Organisation for Animal Health (WOAH) has not yet listed PCV4 as a notifiable disease, but the virus’s potential for economic impact and its cross-species transmission characteristics argue strongly for its inclusion in international swine health monitoring programs.

In conclusion, the epidemiology of PCV4 is defined by its paradoxical characteristics: a virus that has likely circulated for a decade or more in bovine and swine hosts but only recently gained recognition; a pathogen with a broad mammalian host range but a seemingly slow rate of molecular evolution; and a virus that can achieve prevalence rates exceeding 30% in some Chinese pig herds while remaining undetected in others. The true global distribution remains a dark figure, awaiting systematic investigation.

Cross-Species Transmission and Reservoir Hosts

The emergence of Porcine Circovirus 4 (PCV4) in 2019, initially identified in pigs exhibiting severe clinical disease including porcine respiratory disease complex and dermatitis and nephropathy syndrome in Hunan Province, China, has necessitated a paradigm shift in our understanding of circovirus ecology [1, 5]. While PCV4 was first considered a pathogen exclusive to Sus scrofa domesticus, a rapidly accumulating body of molecular evidence has fundamentally challenged this assumption, revealing a far more complex epidemiological landscape characterized by cross-species transmission events and the existence of non-porcine reservoir hosts. This section provides an exhaustive analysis of the current state of knowledge regarding PCV4’s host range, the molecular evidence for spillover events, and the implications for viral maintenance and evolution.

Evidence of PCV4 in Non-Porcine Domestic Animals

The most compelling evidence for PCV4’s ability to transcend species barriers comes from systematic molecular surveillance of domestic animals in China. The seminal work by Xu et al. [2] provided the first definitive demonstration of PCV4 in dairy cattle (Bos taurus). In a large-scale retrospective investigation encompassing 1,170 fecal samples collected from dairy farms across seven cities in Henan Province between 2012 and 2021, a PCV4 positive rate of 2.22% (26/1170) was documented. Critically, this study yielded three full-length and five partial PCV4 genomes, with two strains (NY2012-DC and XC2013-DC) dating back to 2012 and 2013, respectively. This retrospective detection is of profound epidemiological significance, as it indicates that PCV4 has been circulating in dairy cow populations in China for at least a decade prior to its initial discovery in pigs. The complete genome sequences from these bovine-origin strains shared exceptionally high nucleotide identity (97.5–99.5%) with porcine reference strains, suggesting a recent common ancestor and frequent inter-species viral flow [2]. Notably, all bovine samples tested negative for PCV2 and PCV3, indicating that PCV4 is not merely a contaminant but represents a genuine, replicating infection in this species.

Following the discovery in cattle, the host range of PCV4 expanded further with the first global report of PCV4 in domestic dogs (Canis lupus familiaris). Zhang et al. [7] screened 217 fecal samples from diarrheic dogs in Henan Province, China, and detected PCV4 DNA in 5.99% (13/217) of samples, with annual positivity rates of 7.44% in 2020 and 4.17% in 2021. The virus was identified in dogs across six of ten sampled cities, demonstrating a wide geographic distribution within the province. The complete genome of one strain (HN-Dog) was sequenced and exhibited 97.9% to 99.6% identity with reference strains from pigs, raccoon dogs, and foxes [7]. This finding was independently corroborated by Xu et al. [8], who screened 264 dog samples from animal hospitals in Southwest China (2021–2022) and reported a PCV4 prevalence of 1.14% (3/264). The complete genome of strain SCABTC-Dog2022 was obtained and clustered in a geographically coherent branch with strains from Sichuan, Fujian, Hunan, and Inner Mongolia, suggesting a structured, non-random pattern of viral dissemination between canine and porcine populations [8].

The host range of PCV4 has also been extended to include domestic cats (Felis catus). Xu et al. [3] conducted the first molecular survey of PCV4 in felines, analyzing 116 clinical samples from animal hospitals in Sichuan Province (2021–2022). Using a SYBR Green-based real-time PCR assay, PCV4 DNA was detected in 4.31% (5/116) of samples. The complete genome of one strain (SCGA-Cat) was sequenced and demonstrated high nucleotide homology (98.2–99.0%) with PCV4 strains originating from dogs, pigs, dairy cows, and fur animals. Phylogenetic analysis revealed that SCGA-Cat clustered most closely with a porcine strain from Fujian Province, providing direct molecular evidence for a pig-to-cat transmission event or a shared common source [3]. The detection of PCV4 in companion animals (dogs and cats) raises important questions regarding the role of these species as sentinels for environmental contamination or as true biological reservoirs capable of sustaining viral transmission.

Evidence in Fur Animals and Wildlife Reservoirs

The ecological niche of PCV4 extends beyond domestic livestock and companion animals into fur-bearing species, which may serve as important bridging hosts between sylvatic and domestic cycles. Chen et al. [6] reported the detection of PCV4 in a fox and a raccoon dog, with these strains clustering within the PCV4b genotype alongside strains from Suidae, dairy cows, and dogs. This finding is particularly significant given the known role of fur animals in the epidemiology of other circoviruses. The phylogenetic analysis by Xu et al. [4] further suggested that PCV4 shares an ancient ancestor with mink circovirus (MiCV), indicating a deep evolutionary relationship within the Circovirus genus that may predispose these viruses to host-switching events. The detection of PCV4 in raccoon dogs (Nyctereutes procyonoides) and foxes (Vulpes vulpes) is epidemiologically relevant, as these species are often raised in close proximity to swine farms in China and may act as peridomestic reservoirs, facilitating viral maintenance and periodic spillback into pig populations.

Retrospective Evidence and Temporal Dynamics of Cross-Species Transmission

The retrospective analysis of archived samples has been instrumental in reconstructing the evolutionary history of PCV4 and its cross-species transmission dynamics. The detection of PCV4 in dairy cows from 2012 and 2013 [2] predates the first official report of PCV4 in pigs by six to seven years. This temporal discrepancy suggests that PCV4 may have originated in a non-porcine reservoir and subsequently spilled over into swine populations, or that the virus circulated undetected in pigs for an extended period before its formal identification. The high nucleotide homology observed across PCV4 strains from different species and time points indicates a remarkably slow evolutionary rate for this single-stranded DNA virus [2, 4]. Xu et al. [2] analyzed PCV4 strains from three perspectives, cross-time, cross-species, and transboundary, and consistently found high nucleotide conservation, suggesting that PCV4 is under strong purifying selection and that its genome is highly optimized for replication across multiple host species. This genetic stability is in stark contrast to RNA viruses but is characteristic of circoviruses, which have error-prone replication mechanisms yet maintain high sequence conservation due to severe functional constraints on the Rep and Cap proteins.

Phylogenetic Clustering and Genotype-Specific Host Associations

The increasing availability of PCV4 genome sequences from diverse hosts has enabled robust phylogenetic analyses that reveal non-random patterns of host association. Multiple studies have converged on a classification system comprising three major genotypes: PCV4a, PCV4b, and PCV4c [2, 4, 7, 12]. These genotypes are defined by specific amino acid markers: a valine-to-leucine substitution at position 239 in the Rep protein (V239L) and three substitutions in the Cap protein (N27S, R28G, and M212L) [2, 7]. Importantly, the distribution of these genotypes across host species is not uniform. The PCV4b genotype appears to have the broadest host range, encompassing strains from Suidae, fox, dairy cow, dog, and raccoon dog [6]. In contrast, the PCV4c genotype, to which the canine strain SC-GA2022ABTC belongs, is characterized by a specific amino acid pattern (239V for Rep, and 27N, 28R, and 212M for Cap) and has been identified in pigs and dogs from Southwest China [4, 8]. The feline strain SCGA-Cat clustered with a porcine strain from Fujian Province within the PCV4a genotype [3]. These genotype-host associations suggest that while PCV4 can infect multiple species, there may be subtle host-specific adaptations that influence viral fitness and transmission efficiency. The identification of conserved genotype-specific molecular markers provides a valuable tool for tracking the movement of specific viral lineages across species boundaries.

Implications for Reservoir Host Dynamics and Viral Maintenance

The cumulative evidence from molecular epidemiological studies supports a model in which PCV4 is maintained in a multi-host reservoir system. The high prevalence of PCV4 in pigs (ranging from 1.34% to 33.08% depending on the study and geographic region) [4, 11, 12] establishes swine as the primary amplifying host. However, the detection of PCV4 in dairy cows with a prevalence of 2.22% [2], in dogs with a prevalence of 1.14–5.99% [7, 8], and in cats with a prevalence of 4.31% [3] indicates that these species are not merely accidental spillover hosts but may contribute to viral circulation. The long-term retrospective detection in cattle (spanning 2012–2021) [2] is particularly suggestive of sustained transmission within bovine populations, although the directionality of transmission (cattle-to-cattle versus repeated spillover from pigs) remains to be determined. The presence of PCV4 in fur animals [6] and its phylogenetic relationship with mink circovirus [4] raises the possibility of a wildlife reservoir that could serve as a persistent source of infection for domestic animals. The World Organisation for Animal Health (WOAH) has recognized the economic importance of porcine circoviruses, and the expanding host range of PCV4 warrants increased surveillance in both domestic and wild animal populations. The potential for PCV4 to establish itself in wildlife reservoirs, as has been observed for PCV2 and PCV3 in various species, could complicate eradication efforts and necessitate a One Health approach to disease management.

Mechanistic Considerations for Cross-Species Transmission

The molecular mechanisms underlying PCV4’s ability to infect multiple host species are not fully elucidated but likely involve the virus’s reliance on host cell machinery that is highly conserved across mammals. The circular, single-stranded DNA genome of PCV4 encodes two major proteins: the replication-associated protein (Rep) and the capsid protein (Cap). The Cap protein is responsible for receptor binding and host cell entry, and its sequence variability across genotypes may influence host tropism. The specific amino acid substitutions identified in the Cap protein (N27S, R28G, M212L) that define the PCV4a, PCV4b, and PCV4c genotypes [2, 7] are located in regions that may be involved in antigenicity and receptor interaction. The high sequence identity (97.5–99.5%) between PCV4 strains from different hosts [2, 3, 7, 8] suggests that the virus does not require extensive adaptation to infect new species, a characteristic that is consistent with a generalist pathogen. This is in contrast to PCV2, which has a more restricted host range in nature, although experimental infection of mice has been demonstrated [22]. The ability of PCV4 to infect such a phylogenetically diverse array of hosts, including artiodactyls (pigs, cattle), carnivores (dogs, cats, foxes, raccoon dogs), is remarkable and suggests that the cellular receptor for PCV4 is widely distributed among mammalian species. The Centers for Disease Control and Prevention (CDC) and the Food and Agriculture Organization (FAO) have emphasized the importance of monitoring emerging viruses with broad host ranges, as they pose a greater risk for sustained transmission and potential zoonotic spillover, although no evidence of PCV4 infection in humans has been reported to date.

Diagnostic Methods for PCV4 Detection

The emergence of Porcine Circovirus 4 (PCV4) as a novel pathogen within the Circoviridae family has necessitated the urgent development and validation of robust, sensitive, and specific diagnostic platforms. Since its initial identification in 2019 in Hunan Province, China, from pigs exhibiting porcine respiratory disease complex and dermatitis and nephropathy syndrome [1, 5], PCV4 has been detected across multiple provinces in China, South Korea, and in an expanding range of non-porcine hosts, including dairy cows, dogs, cats, and fur animals [2, 3, 7, 8]. This rapidly broadening host range and the virus's demonstrated pathogenicity in experimental piglet infections underscore the critical need for diagnostic methods capable of not only detecting active infections but also facilitating large-scale epidemiological surveillance, retrospective analyses, and studies into cross-species transmission dynamics. The following section provides an exhaustive examination of the molecular, serological, and sequencing-based diagnostic modalities currently available for PCV4, with a focus on their analytical performance characteristics, practical applications, and limitations.

Real-Time Quantitative PCR (qPCR) Assays: The Cornerstone of Detection

Quantitative real-time PCR (qPCR) has emerged as the primary diagnostic tool for PCV4 detection, owing to its high sensitivity, specificity, and capacity for absolute quantification. The development of these assays has centered on targeting the conserved open reading frame 2 (ORF2) gene, which encodes the immunogenic capsid (Cap) protein.

TaqMan Probe-Based Assays

The first fully validated TaqMan-based real-time PCR for specific PCV4 detection was established by Chen et al. [1]. This assay, targeting the ORF2 gene, demonstrated extraordinary analytical performance: an amplification efficiency of 99.6%, a regression coefficient (R²) of 1.000, and a limit of detection (LOD) of 2.2 × 10¹ DNA copies per reaction. The intra- and inter-assay coefficients of variation were exceptionally low (<1.67%), indicating high reproducibility. When applied to 67 clinical samples from Sichuan Province, including blood, tissue, saliva, and semen, the assay yielded a 4% positivity rate, confirming PCV4 circulation in that region [1]. Critically, the assay showed no cross-reactivity with other porcine circoviruses (PCV1, PCV2, PCV3) or other common swine pathogens, a prerequisite for accurate differential diagnosis. This TaqMan approach offers the advantage of a sequence-specific probe that adds a layer of specificity beyond that of SYBR Green assays, reducing the risk of false positives from primer-dimers or non-specific amplification.

Multiplex Real-Time PCR for Co-infection Analysis

Given the frequent occurrence of co-infections in porcine respiratory disease complex (PRDC) and porcine circovirus-associated disease (PCVAD), multiplex assays capable of simultaneously detecting PCV4 alongside other pathogens are invaluable. Zou et al. [11] developed a TaqMan-probe-based multiplex qPCR for the simultaneous differential detection of PCV2, PCV3, and PCV4. This assay incorporated an internal positive control (porcine β-Actin gene) to monitor sample quality and extraction efficiency. The assay exhibited a detection limit of 10¹ copies/μL for each virus, with no cross-reactivity among the three circovirus types or with other porcine viral pathogens [11]. The clinical utility was demonstrated on 535 samples from East China (2020–2022), revealing individual positive rates of 35.33% for PCV2, 40.37% for PCV3, and 33.08% for PCV4, with a triple-co-infection rate of 28.22%. These data underscore the diagnostic complexity of circovirus infections and the necessity of multiplexed approaches.

Similarly, Xu et al. [12] established a SYBR Green I-based duplex qPCR for the simultaneous detection of PCV2 and PCV4. While SYBR Green assays are less specific than probe-based methods, they are more cost-effective and suitable for initial screening. This duplex assay achieved LODs of 80.2 copies/μL for PCV2 and 58.6 copies/μL for PCV4. Applied to 133 clinical samples from Henan Province, it identified PCV4 in 33.33% of samples, PCV2 in 63.16%, and co-infection in 21.05% [12]. Chen et al. [6] extended this concept to a SYBR Green I-based duplex qPCR for PCV4 and porcine reproductive and respiratory syndrome virus (PRRSV), achieving LODs of 41.1 copies/μL and 81.5 copies/μL, respectively. This assay detected a co-infection rate of 8% for PCV4 and 12% for PRRSV in 150 clinical samples from Shaanxi and Henan Provinces [6]. The development of these multiplex platforms directly addresses the diagnostic challenge posed by the overlapping clinical presentations of PCV2, PCV3, PCV4, and PRRSV infections, which can be clinically indistinguishable [10, 11, 25].

Isothermal Amplification Methods: Recombinase-Aided Amplification (RAA)

While qPCR remains the gold standard, its requirement for thermal cycling equipment limits deployment in field settings or resource-limited laboratories. Isothermal amplification technologies offer a compelling alternative. Sun et al. [13] developed a duplex real-time recombinase-aided amplification (RAA) assay for the simultaneous detection of PCV3 and PCV4. This assay represents a significant technological advancement, as it completes amplification within 20 minutes at a constant temperature of 39°C, eliminating the need for a thermocycler. The assay achieved a detection limit of 73.67 copies/reaction for each circovirus (at 95% probability by probit regression analysis) and demonstrated high specificity, with no cross-reactivity against PCV2 or other important porcine viruses [13]. The intra- and inter-group coefficients of variation ranged from 2.08% to 4.97%, indicating good reproducibility.

Comparative analysis with qPCR on 60 clinical samples and artificially spiked samples showed high congruence (kappa values of 0.966 and 1.0, respectively), validating the RAA assay's effectiveness for clinical diagnosis [13]. This portable, rapid, and accurate method is particularly suited for on-farm diagnostics, outbreak investigations, and surveillance in regions without access to centralized laboratory infrastructure. The World Organisation for Animal Health (WOAH) has increasingly emphasized the need for field-deployable diagnostics for emerging infectious diseases, and RAA-based platforms align perfectly with this strategic goal.

Cross-Species Diagnostic Applications and Retrospective Surveillance

One of the most striking findings in PCV4 research is its detection across multiple non-porcine species, necessitating diagnostic validation in diverse host backgrounds.

Detection in Dogs, Cats, and Dairy Cows

Zhang et al. [7] and Xu et al. [8] independently reported the first molecular detection of PCV4 in dogs. Both studies used real-time PCR assays targeting the ORF2 gene. Zhang et al. [7] screened 217 fecal samples from diarrheic dogs in Henan Province, finding a 5.99% positivity rate (7.44% in 2020; 4.17% in 2021). Xu et al. [8] examined 264 dog samples from animal hospitals in Southwest China, reporting a lower prevalence of 1.14% (3/264). These studies not only confirmed PCV4 circulation in canids but also provided the first complete genome sequence from a dog (HN-Dog), establishing a crucial reference for future cross-species diagnostic evaluations [7]. The association between PCV4 detection and diarrhea in dogs warrants further investigation, but it underscores the need for diagnostic panels that include PCV4 in canine enteric disease workups.

Similarly, Xu et al. [3] detected PCV4 in 5 of 116 (4.31%) cat samples from Sichuan Province using a SYBR Green-based real-time PCR. The complete genome of the cat-origin strain (SCGA-Cat) shared 98.2–99.0% nucleotide identity with strains from pigs, dogs, and dairy cows, demonstrating the genetic homogeneity of PCV4 across species [3]. This finding is particularly significant from a One Health perspective, as it raises questions about the potential for reverse zoonotic transmission from pigs to companion animals and the role of felines as sentinel species for PCV4 surveillance.

In a landmark retrospective investigation, Xu et al. [2] screened 1,170 fecal samples from dairy cows in Henan Province (collected from 2012 to 2021) using a qPCR capable of detecting PCV2, PCV3, and PCV4. While all samples were negative for PCV2 and PCV3, 2.22% (26/1170) were positive for PCV4. Crucially, two complete genomes (NY2012-DC and XC2013-DC) were obtained from samples collected in 2012 and 2013, respectively, demonstrating that PCV4 has been circulating in Chinese dairy cow populations for at least a decade before its formal discovery in pigs [2]. This retrospective data is diagnostic gold, it validates the qPCR's ability to detect historical material (likely degraded, low-titer samples) and provides critical evolutionary context, indicating a slow evolutionary rate for PCV4.

Surveillance in Swine Populations

Multiple independent studies have applied qPCR-based diagnostics to assess PCV4 prevalence in swine. In the Southwest of China, Xu et al. [4] reported a low prevalence of 1.34% (5/374) in diseased pigs collected during 2021–2022, using a real-time PCR assay. Tian et al. [5] used a conventional PCR targeting the partial Cap gene and found a substantially higher positivity rate of 25.40% (16/63) in Henan and Shanxi Provinces (2018–2019), with 50% of farms (12/24) positive. This disparity highlights the influence of sample type, geographic region, and time period on diagnostic outcomes. Yang et al. [10] conducted a comprehensive survey in Xinjiang Province (2022–2024) using real-time PCR for PCV1, PCV2, PCV3, and PCV4, reporting a PCV4 positive rate of 17% among 453 deceased pigs. These studies collectively demonstrate that qPCR-based surveillance is essential for mapping the spatial and temporal distribution of PCV4, which appears to be widespread but at variable prevalence across China.

Genotyping, Sequencing, and Phylogenetic Analysis as Diagnostic Tools

Beyond detection, molecular characterization through genome sequencing is critical for understanding PCV4's genetic diversity, evolutionary trajectory, and potential for virulence.

Genotype Classification

Phylogenetic analyses based on complete genome sequences have consistently identified three distinct genotypes: PCV4a, PCV4b, and PCV4c [2, 4, 7, 12]. This classification is supported by specific amino acid markers: a V239L substitution in the Rep protein (ORF1) and three substitutions in the Cap protein (N27S, R28G, and M212L) [7, 8]. These markers serve as genotype-specific molecular signatures that can be used diagnostically to classify field strains. For instance, the dog-origin strain HN-Dog clustered within PCV4b, along with strains from pigs, raccoon dogs, and foxes [7]. The cat-origin strain SCGA-Cat was closely related to a pig strain from Fujian Province, falling within PCV4c [3]. This genotyping capability is essential for epidemiological tracing and for assessing whether certain genotypes are associated with particular host species or clinical presentations.

Retrospective Evolutionary Analysis

The sequencing of PCV4 genomes from historical samples has provided profound evolutionary insights. The detection of PCV4 in dairy cows from 2012 and 2013 [2] suggests that PCV4 has been circulating at low levels for years prior to its initial identification. Comparative analysis of these historical sequences with contemporary isolates reveals high nucleotide homology (97.5–99.5%), indicating a notably slow evolutionary rate for this single-stranded DNA virus [2]. This has direct diagnostic implications: assays designed based on modern reference strains are likely to detect historical variants, and vaccine development efforts can target conserved epitopes. Furthermore, the identification of a specific amino acid pattern (239V for Rep, 27N, 28R, and 212M for Cap) as a marker for PCV4c [4] allows for rapid genotype assignment from partial sequencing data.

Functional Genome Analysis

Detailed genomic characterization has revealed conserved functional elements essential for PCV4 replication. Chen et al. [6] predicted a "stem-loop" structure within the PCV4 genome, including a 17-bp iterative sequence serving as the stem structure, with H1/H2 (12-CGGCACACTTCGGCAC-27) as the minimal binding site for Rep protein. These structural predictions, derived from sequencing data, are vital for understanding viral replication mechanisms and for designing targeted antiviral strategies. Sequence analysis also allows for the prediction of putative recombination events, which, although less documented in PCV4 compared to PCV2, remain a potential mechanism for generating genetic diversity [12].

Technical Considerations and Assay Validation Parameters

The reliability of any diagnostic method hinges on rigorous validation. Across the reviewed literature, several critical parameters are consistently reported.

Sensitivity and Specificity

The LOD for PCV4 qPCR assays ranges from 2.2 × 10¹ copies/reaction [1] to 73.67 copies/reaction for RAA [13]. The high sensitivity of these assays is necessary given that PCV4 viral loads in clinical samples may be low, particularly in subclinical infections or in non-porcine hosts. Specificity is ensured by careful primer/probe design targeting regions of ORF2 that are conserved among PCV4 strains but distinct from other circoviruses. All validated assays report no cross-reactivity with PCV1, PCV2, PCV3, or other common swine viruses [1, 11, 13].

Reproducibility

Intra- and inter-assay coefficients of variation are routinely <5% for qPCR assays [1, 11] and <5% for RAA [13], confirming high reproducibility. This is critical for multi-center surveillance studies and for comparing results across different laboratories.

Sample Types

PCV4 has been detected in a wide variety of sample matrices, including blood, serum, tissue (lung, lymph node, spleen), saliva swabs, fecal swabs, and semen [1, 2, 5, 7]. The ability to use non-invasive samples (feces, saliva) is particularly advantageous for large-scale surveillance and for testing valuable breeding stock. For cross-species studies, fecal samples from dogs and cats, and fecal or tissue samples from dairy cows, have proven suitable for PCV4 detection [2, 3, 7].

Endogenous Controls

The inclusion of endogenous internal controls (e.g., porcine β-Actin) in multiplex assays is standard practice [11]. This controls for nucleic acid extraction efficiency, the presence of PCR inhibitors, and overall sample quality, reducing the risk of false-negative results.

Future Directions: Serological and Next-Generation Sequencing Diagnostics

Currently, the diagnostic landscape for PCV4 is dominated by nucleic acid detection methods. However, serological assays, such as enzyme-linked immunosorbent assays (ELISAs) for the detection of PCV4-specific antibodies, remain conspicuously absent from the literature. As the field matures, the development of serological tools will be critical for assessing prior exposure, seroprevalence, and the immune response to infection or vaccination, particularly given the challenges of detecting low-level viral shedding in recovered animals.

Furthermore, the advent of high-throughput sequencing (HTS) and metagenomics offers a promising avenue for unbiased detection of PCV4 and other novel or unexpected pathogens. While HTS has been applied to the discovery of other porcine viruses [23, 24], its use for PCV4 diagnostics is still nascent. The sensitivity of HTS for adventitious virus detection in complex matrices has been demonstrated [21], and as sequencing costs decline, it may become a valuable tool for comprehensive viral surveillance in swine and other species. The ongoing application of these advanced molecular techniques will be essential for accurately defining the global distribution, host range, and clinical significance of PCV4.

Clinical Significance and Disease Associations

The clinical significance of Porcine Circovirus Type 4 (PCV4) is an evolving and increasingly complex area of study. Since its initial identification in 2019 from pigs exhibiting severe clinical signs, including porcine respiratory disease complex (PRDC) and porcine dermatitis and nephropathy syndrome (PDNS), in Hunan Province, China, PCV4 has emerged as a pathogen of substantial concern for the global swine industry [1, 5]. While the full spectrum of PCV4-induced disease is still under intensive investigation, cumulative evidence from molecular epidemiology, cross-species transmission studies, and associated clinical presentations strongly indicates that PCV4 is a primary or contributory agent in a range of porcine disease syndromes. The challenge for veterinary diagnosticians and clinicians lies in disentangling the specific contributions of PCV4 from those of other ubiquitous pathogens, particularly given the high rates of co-infection with PCV2 and PCV3 [10-12].

PCV4 in Swine: Primary Pathogenicity and Clinical Syndromes

The detection of PCV4 in pigs has been consistently associated with significant clinical presentations. The seminal study that led to the discovery of PCV4 identified the virus in herds suffering from PRDC and PDNS [1, 5]. Subsequent epidemiological investigations have reinforced this connection. A study across Henan and Shanxi Provinces, for example, detected PCV4 in 25.40% of clinical samples, with the virus found in pigs displaying a range of clinical presentations, including respiratory distress and systemic illness [5]. This establishes a direct correlation between PCV4 infection and overt clinical disease, similar to the established pathogenesis of PCV2. The virus has been proven to be pathogenic to piglets in experimental settings, confirming its capacity to act as a primary pathogen rather than merely an incidental finding [2, 4]. Field studies in Southwest China during 2021-2022 detected PCV4 in diseased pigs, further corroborating its role as a pathogen of concern in commercial herds [4].

The prevalence of PCV4, while lower than that of PCV2 in some regions, is nonetheless substantial. Data from East China (2020-2022) revealed an individual positive rate of 33.08% for PCV4, a figure that is alarmingly comparable to the 35.33% for PCV2 and 40.37% for PCV3 in the same sample set [11]. In Henan province, a separate study found a PCV4 positive rate of 33.33% in clinical samples [12]. This high prevalence indicates a widespread distribution of PCV4 within endemic regions and a significant potential for clinical impact. Critically, PCV4 is rarely found in isolation. Co-infections are the rule, rather than the exception. The same East China study reported mixed infection rates for PCV2 and PCV4 at 30.09% and for PCV3 and PCV4 at 30.84%, with a triple co-infection rate of all three circoviruses reaching 28.22% [11]. Similarly, co-infection of PCV4 with porcine reproductive and respiratory syndrome virus (PRRSV) has been documented, particularly in lung tissue from suckling pigs with respiratory symptoms [6]. This complex co-infection ecology complicates the attribution of specific pathological lesions to PCV4 alone. However, the high frequency of its detection in these multi-pathogen scenarios suggests that PCV4 acts as a key component of the PRDC and PCVAD (porcine circovirus-associated disease) complexes, probably exacerbating disease severity through synergistic interactions with other pathogens.

Cross-Species Transmission: Expanding the Host Range and Ecological Niche

One of the most clinically and epidemiologically significant aspects of PCV4 is its documented capacity for cross-species transmission. This represents a major departure from the host range traditionally associated with PCV2 and PCV3 and raises critical questions about PCV4's evolutionary origins and its potential to establish novel reservoir hosts. The virus has been detected in a remarkable array of non-porcine species, including dairy cows, dogs, cats, foxes, and raccoon dogs [2-4, 7, 8]. This broad host range suggests a unique adaptive capability, possibly linked to specific molecular markers in its capsid protein.

The clinical significance of PCV4 in these non-porcine hosts is an area of active research. In dogs, PCV4 was first detected in fecal samples from diarrheic animals in Henan Province, with a total positivity rate of 5.99% [7]. The complete genome sequenced from a dog affected with diarrhea showed high homology to pig-derived strains, confirming the cross-species event [7, 8]. The study explicitly states that "the association between PCV4 infection and diarrhea warrants further study" [7]. In cats, PCV4 was identified in 4.31% of clinical samples from animal hospitals in Sichuan Province. While no specific clinical syndrome was definitively linked, the detection of PCV4 in feline clinical settings necessitates further investigation into its role as a potential feline pathogen [3]. The detection of PCV4 in dairy cows is perhaps the most alarming. A retrospective study revealed that PCV4 has been circulating in dairy cows in Henan Province for at least a decade, with a positive rate of 2.22% [2]. The identification of strains from 2012 and 2013 indicates that PCV4 was present in cattle prior to its "discovery" in pigs in 2019 [2]. This suggests that cattle may serve as a historical reservoir or an alternative host that predates its emergence in swine. The finding of PCV4 in fox and raccoon dogs further expands the ecological network, indicating its circulation in wildlife that could act as bridging hosts to domestic animals [4, 7].

From a clinical perspective, the implications are profound. If PCV4 can cause or contribute to enteric or respiratory disease in companion animals like dogs and cats, this represents a new differential diagnosis for veterinarians treating these species. The detection of PCV4 in a dog exhibiting diarrhea with no other known pathogen suggests a primary enteropathogenic potential [7]. For the cattle industry, the long-term circulation of PCV4 without a recognized clinical syndrome is a "silent" epidemic. It raises the possibility that PCV4 contributes to subclinical production losses (e.g., reduced feed efficiency, decreased milk yield) or that its clinical expression is masked by more common bovine pathogens. The role of cattle as a potential mixing vessel for viral evolution also poses a risk for the emergence of new, more virulent strains. These findings align with the World Organisation for Animal Health (WOAH) guidelines on emerging diseases, emphasizing the need for surveillance across species boundaries.

Pathogenesis, Co-infection Dynamics, and Diagnostic Challenges

Understanding the clinical significance of PCV4 requires a deep dive into its pathogenesis, which is still being elucidated. The virus, like other circoviruses, encodes a Rep protein for replication and a Cap protein that forms the viral capsid and is the primary target for the host immune response [1]. The high frequency of co-infection with PCV2 and other viruses is a critical clue to its pathogenic mechanism. Following the model established for PCV2, PCV4 is likely an immunosuppressive agent. PCV2 is well-known for its ability to infect and dysregulate immune cells, such as macrophages and dendritic cells, leading to immunosuppression that predisposes the host to secondary bacterial and viral infections [15, 17]. Given the genetic similarities and the frequent co-detection of PCV4 with PRRSV, PCV2, and Actinobacillus pleuropneumoniae, a similar mechanism of immunosuppression is highly probable [6, 15]. The study of PCV2's role in PRDC, where it promotes the survival of bacterial pathogens by inhibiting reactive oxygen species production in alveolar macrophages, provides a direct parallel for the potential role of PCV4 in such polymicrobial respiratory diseases [15].

The clinical presentation of PCV4 infection is thus likely to be highly contextual, depending on the host's age, immune status, and the presence of co-infecting pathogens. In young piglets, PCV4 could be a key trigger for post-weaning multisystemic wasting syndrome (PMWS), a syndrome historically linked to PCV2 but found in association with other pathogens like PCV3, classical swine fever virus, and porcine parvovirus [17]. The detection of PCV4 in samples from pigs with PRDC and PDNS confirms its presence in these clinically distinct disease complexes [1, 5]. The high rates of co-infection with PCV2 and PCV3 (upwards of 30%) create a diagnostic challenge: isolating the specific contribution of PCV4 to the overall pathology requires advanced, simultaneous detection methods like the multiplex real-time PCR assays or recombinase aided amplification (RAA) assays that have been developed specifically for this purpose [11, 13]. These tools are essential for understanding the role of PCV4 in mixed infections, as clinical signs alone are insufficient for differentiation.

The presence of PCV4 in biological products, specifically its detection as a potential adventitious agent in materials derived from pigs (such as heparin, a topic of significant concern for vaccine safety), highlights another layer of clinical significance [14, 21]. While studies have not uniformly found PCV4 in products like heparin [14], the precedent set by PCV2 contamination of rotavirus vaccines underscores the need for rigorous screening of porcine-derived biopharmaceuticals for PCV4 [14]. This has direct implications for human health regulatory bodies such as the CDC, which monitor zoonotic and adventitious agents in biologics.

The zoonotic potential of PCV4, while currently unconfirmed, cannot be dismissed. The detection of PCV4 in animals that are in close contact with humans, dogs, cats, and cattle, warrants vigilance. The historical precedent of Streptococcus suis emerging as a zoonotic agent from swine [26] and the association of Taenia solium with pigs [27] remind us of the potential for porcine pathogens to cross into human populations. PCV4's presence in companion animals creates a vector for human exposure, particularly for immunocompromised individuals. Until definitive studies are conducted, PCV4 should be considered a potential zoonotic risk.

In conclusion, the clinical significance of PCV4 is multifaceted, extending from its role as a primary pathogen in swine causing respiratory and systemic disease to its ability to infect a diverse range of non-porcine hosts. Its high rate of co-infection with other porcine circoviruses and respiratory pathogens points to a synergistic role in complex disease syndromes. The challenge for clinicians is to integrate PCV4 into the differential diagnosis for PRDC, PDNS, and enteric disease in pigs, while also considering its potential role in companion animal illnesses. The development of high-throughput, sensitive diagnostic tools is paramount for future research to precisely define the pathological impact of PCV4 as a single agent and in concert with other members of the swine virome.

Prevention and Control Strategies

The emergence of Porcine Circovirus 4 (PCV4) as a novel pathogen within the Circoviridae family presents a formidable challenge to global swine health management, particularly given its demonstrated capacity for cross-species transmission into dairy cattle, dogs, cats, and fur-bearing animals [2, 3, 7, 8]. The development of comprehensive prevention and control strategies for PCV4 must be predicated upon a multi-layered approach that integrates advanced molecular surveillance, rigorous biosecurity protocols, strategic vaccination programs, and targeted antiviral interventions. Unlike its better-characterized counterpart PCV2, for which commercial vaccines have been available since 2006, PCV4 currently lacks any licensed immunobiological product, rendering control efforts heavily dependent upon proactive detection and containment measures [9, 20].

Molecular Surveillance and Diagnostic Infrastructure

The cornerstone of any effective PCV4 control program is the establishment of robust, high-throughput diagnostic systems capable of detecting the virus at low copy numbers across diverse clinical matrices. The development of a TaqMan-based real-time PCR assay targeting the ORF2 gene has demonstrated exceptional analytical sensitivity, with a detection limit of 2.2 × 10¹ DNA copies per reaction and amplification efficiency of 99.6%, making it an indispensable tool for early identification of infected herds [1]. This assay’s specificity is critical, as it shows no cross-reactivity with PCV1, PCV2, PCV3, or other common porcine pathogens, thereby eliminating false-positive results that could trigger unnecessary quarantine actions [1]. Furthermore, the establishment of a SYBR Green I-based duplex quantitative PCR for simultaneous detection of PCV4 and porcine reproductive and respiratory syndrome virus (PRRSV) addresses the clinical reality of frequent co-infections, with studies in Shaanxi and Henan provinces revealing PCV4 detection rates of 8.00% and PRRSV rates of 12.00%, and a notable co-infection case identified in lung tissue from a suckling pig with respiratory symptoms [6]. The multiplex approach described by Zou et al. (2022) represents the gold standard for comprehensive circovirus surveillance, enabling differential diagnosis of PCV2, PCV3, and PCV4 in a single reaction, with individual positive rates of 35.33%, 40.37%, and 33.08% respectively, and a triple co-infection rate of 28.22% across 535 clinical samples from East China [11]. Such multiplex capacity is essential for distinguishing the etiological agent in cases of porcine dermatitis and nephropathy syndrome (PDNS) and reproductive disorders, where clinical presentations overlap considerably among circovirus species [11].

The advent of recombinase-aided amplification (RAA) technology offers a paradigm shift for field-deployable diagnostics, with the duplex real-time RAA assay for PCV3 and PCV4 achieving a detection limit of 73.67 copies per reaction within 20 minutes at a constant 39°C, eliminating the need for thermal cycling equipment [13]. This assay exhibits a kappa value of 0.966-1.000 when compared with conventional qPCR, indicating near-perfect concordance, and its portability makes it ideally suited for surveillance in resource-limited settings or for rapid outbreak investigation [13]. The retrospective molecular analysis of PCV4 in dairy cows from Henan Province, spanning 2012-2021, underscores the critical importance of archival surveillance in understanding viral emergence dynamics; the detection of PCV4 in fecal samples with a 2.22% positivity rate, including strains from 2012 and 2013, indicates that the virus has been circulating undetected for at least a decade prior to its initial identification in 2019, highlighting the need for systematic biobanking and periodic retrospective screening [2].

Biosecurity and Herd Management Protocols

The demonstrated cross-species transmission of PCV4 necessitates a One Health approach to biosecurity that extends beyond traditional swine-focused measures. The detection of PCV4 in 5.99% of diarrheic dogs in Henan Province, with complete genome sequencing confirming high homology (97.9-99.6%) to porcine-derived strains, establishes canines as potential mechanical vectors or biological reservoirs capable of reintroducing the virus into swine operations [7]. Similarly, the identification of PCV4 in 4.31% of cats from animal hospitals in Sichuan Province, with the SCGA-Cat strain clustering closely with a pig-derived strain from Fujian Province, suggests that feline populations may serve as sentinel species or active participants in viral maintenance [3]. The presence of PCV4 in dairy cattle, with a positive rate of 2.22% across 1,170 fecal samples and the successful sequencing of three complete genomes showing 97.5-99.5% identity with reference strains, indicates that ruminants represent a significant and previously unrecognized reservoir [2]. These findings mandate that biosecurity protocols for swine farms must incorporate buffer zones separating pig facilities from areas frequented by companion animals, implement strict protocols for feral cat and dog population management, and enforce hygienic measures for personnel who may have contact with non-porcine species.

Within swine operations, the high prevalence of co-infections necessitates targeted intervention strategies. The detection of PCV4 in 33.33% of clinical samples from Henan Province, with a co-infection rate of 21.05% with PCV2, indicates that management protocols designed for PCV2 control may be insufficient to prevent PCV4 transmission [12]. The demonstration that PCV2 promotes Actinobacillus pleuropneumoniae survival in porcine alveolar macrophages by suppressing reactive oxygen species production and reducing TNF-α, IFN-γ, and IL-4 expression provides a mechanistic basis for the observed synergy between circovirus infections and bacterial respiratory pathogens [15]. Consequently, control programs must integrate comprehensive pathogen monitoring, with particular attention to the porcine respiratory disease complex (PRDC). The statistical association between novel parvoviruses PPV2-4 and PCV2 in PRDC and PCVAD cases, as demonstrated by latent class analysis showing clustering co-factor associations, further emphasizes the complexity of polymicrobial interactions that must be addressed through holistic herd health management [16].

Vaccination Strategies and Immunological Control

The absence of a commercial PCV4 vaccine represents the most critical gap in current control strategies, necessitating urgent research and development efforts. Drawing from the successful precedent of PCV2 vaccination, which dramatically reduced PCV3/PCV2 co-infection rates from 47% in 2000 to 3% in 2012 following vaccine introduction in 2006, the development of a PCV4 vaccine is expected to have similarly transformative effects on viral prevalence and disease severity [9]. The genetic characterization of PCV4 strains has identified three distinct genotypes, PCV4a, PCV4b, and PCV4c, defined by specific amino acid markers including V239L in the Rep protein and N27S, R28G, and M212L in the Cap protein [4, 7]. This genotypic diversity must be considered in vaccine design to ensure broad cross-protection. The oral vaccine platform utilizing live-attenuated Salmonella Typhimurium to deliver PCV2 Cap and Rep antigens has demonstrated remarkable efficacy in eliciting mucosal and systemic immunity, with enhanced PCV2-specific sIgA, serum IgG, and neutralizing antibodies, as well as robust T-lymphocyte proliferation characterized by synchronized Th1 and Th2 responses [28]. This platform offers particular advantages for PCV4 vaccine development, as oral administration can induce protective mucosal immunity as the first line of defense against enteric and respiratory transmission, and the pro-eukaryotic expression system enables antigen presentation in a conformation that mimics natural infection [28].

The challenge of vaccine development is compounded by the virus’s demonstrated ability to infect non-porcine species, raising questions about the potential need for multivector or multivalent approaches. The identification of PCV4 in minks and raccoon dogs, coupled with phylogenetic evidence suggesting an ancient ancestor with mink circovirus, indicates that the virus may have originated in non-porcine hosts and subsequently adapted to swine [4, 7]. This evolutionary history suggests that vaccine strategies must account for potential antigenic variation across host species. Furthermore, the observation that glutamine starvation enhances PCV2 replication via p38 MAPK phosphorylation, mediated by reduced glutathione levels, suggests that nutritional modulation may serve as an adjunctive control measure [18]. The incorporation of glutamine supplementation into swine diets could theoretically reduce PCV4 replication by maintaining intracellular glutathione homeostasis and preventing p38 MAPK activation, although specific studies on PCV4 are lacking [18].

Antiviral and Immunomodulatory Interventions

In the absence of a licensed vaccine, antiviral compounds offer a temporary but critical line of defense. The veterinary drug Amixin® (dihydrochloride 2,7-bis[2-(diethylamine)ethoxy]fluorene-9-one, AMX) has demonstrated significant antiviral activity against PCV2, with concentrations ≥0.125 mg/ml inhibiting 20-75% of infective activity in PK-15 and Marc-145 cell cultures, and doses of 540 mg administered to suckling piglets showing no toxicity [29]. The proposed mechanism involves direct viral inactivation and potential inhibition of bacteriophage-mediated antibiotic resistance in co-infecting bacteria, suggesting that AMX could provide dual benefits in managing circovirus-bacterial coinfections [29]. However, the moderate toxicity observed at doses ≥1 mg/ml necessitates careful dose optimization for PCV4 applications. The observation that AMX treatment restored antibiotic sensitivity in Mycoplasma and Pasteurella isolates from chickens, likely through bacteriophage inhibition, indicates that antiviral therapy may have indirect benefits for managing secondary bacterial infections that complicate PCV4-associated disease [29].

Eradication and Certification Programs

The establishment of PCV4-free herds requires stringent testing protocols combined with repopulation strategies. The low prevalence of PCV4 in Southwest China (1.34% at sample level) suggests that regional eradication may be feasible if infected herds are identified early and depopulated [4]. However, the retrospective detection of PCV4 in dairy cows from 2012 indicates that the virus can persist in populations for extended periods without causing overt clinical disease, complicating eradication efforts [2]. The development of specific-pathogen-free (SPF) herds for PCV4 would require rigorous testing using the highly sensitive TaqMan PCR assay, with a detection limit of 2.2 × 10¹ copies, and the implementation of stringent quarantine protocols for incoming animals [1]. The demonstration that PCV4 can be detected in semen samples raises concerns about vertical and venereal transmission, necessitating the inclusion of semen testing in certification programs [1]. The potential for environmental persistence, suggested by the detection of PCV4 in feed samples from PDCoV-affected farms, indicates that contaminated feedstuffs may serve as fomites, requiring attention to feed biosecurity [24].

The implementation of area-wide control programs, analogous to those used for classical swine fever and PRRSV eradication, would benefit from standardized reporting and genotyping databases. The phylogenetic analysis of PCV4 strains from diverse hosts and geographic regions has established a foundation for molecular epidemiology, with the identification of three genotypes and specific molecular markers enabling tracking of viral spread and identification of transmission pathways [4, 7]. International organizations such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) should establish surveillance frameworks and reporting standards for emerging circoviruses, given their demonstrated potential for cross-species transmission and economic impact on swine production. The detection of PCV4 in South Korea indicates that the virus is not confined to China, underscoring the need for global surveillance networks [1].

In conclusion, the prevention and control of PCV4 requires an integrated strategy combining advanced molecular diagnostics, comprehensive biosecurity protocols addressing cross-species transmission, urgent vaccine development leveraging proven platforms such as live-attenuated Salmonella vectors, and judicious use of antiviral compounds pending vaccine availability. The success of these efforts will depend on international collaboration, standardized surveillance protocols, and sustained investment in research to elucidate the pathogenesis, transmission dynamics, and ecological niche of this emerging pathogen.

References

[1] Chen W, Jiang D, Xiao L, Zhang P, Luo Y, Yang Z, et al.. Development of a Real-time TaqMan PCR Assay for The Detection of Porcine Circovirus 4. Journal of Veterinary Research. 2022. DOI: https://doi.org/10.2478/jvetres-2022-0004

[2] Xu T, Chen X, Fu Y, Ai Y, Wang D, Wei Z, et al.. Cross-species transmission of an emerging porcine circovirus (PCV4): First molecular detection and retrospective investigation in dairy cows.. Veterinary Microbiology. 2022. DOI: https://doi.org/10.1016/j.vetmic.2022.109528

[3] Xu T, Deng L, Jian Z, Xu L, Li F, Lai S, et al.. First report on identification and genomic analysis of a novel porcine circovirus (porcine circovirus 4) in cats. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1258484

[4] Xu T, You D, Wu F, Zhu L, Sun X, Lai S, et al.. First molecular detection and genetic analysis of porcine circovirus 4 in the Southwest of China during 2021–2022. Frontiers in Microbiology. 2022. DOI: https://doi.org/10.3389/fmicb.2022.1052533

[5] Tian R, Zhao Y, Cui J, Zheng H, Xu T, Hou C, et al.. Molecular detection and phylogenetic analysis of Porcine circovirus 4 in Henan and Shanxi Provinces of China.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13714

[6] Chen X, Zhao Y, Liu X, Han Y, Zhang Y, Hou C, et al.. Molecular detection and genetic characteristics of a novel porcine circovirus (porcine circovirus 4) and porcine reproductive and respiratory syndrome virus in Shaanxi and Henan Provinces of China.. Comparative Immunology, Microbiology & Infectious Diseases. 2023. DOI: https://doi.org/10.1016/j.cimid.2023.102009

[7] Zhang L, Wang T, Fu P, Zhao Y, Li H, Wang D, et al.. First Molecular Detection and Genetic Analysis of a Novel Porcine Circovirus (Porcine Circovirus 4) in Dogs in the World. Microbiology spectrum. 2023. DOI: https://doi.org/10.1128/spectrum.04333-22

[8] Xu T, Chen L, Huang B, Zhu L, Sun X, Lai S, et al.. The first dog-origin porcine circovirus type 4 complete genomic sequence have high homology with that of pig-derived strains. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1121177

[9] Kroeger M, Stott C, Shen H, Li G, Main R, Bush E, et al.. Epidemiological and molecular retrospective analysis of porcine circovirus 3 in the US grower-finisher herd.. Infection, Genetics and Evolution. 2025. DOI: https://doi.org/10.1016/j.meegid.2025.105819

[10] Yang K, Wang Z, Wang X, Bi M, Hu S, Li K, et al.. Epidemiological investigation and analysis of the infection of porcine circovirus in Xinjiang. Virology Journal. 2024. DOI: https://doi.org/10.1186/s12985-024-02504-w

[11] Zou J, Liu H, Chen J, Zhang J, Li X, Long Y, et al.. Development of a TaqMan-Probe-Based Multiplex Real-Time PCR for the Simultaneous Detection of Porcine Circovirus 2, 3, and 4 in East China from 2020 to 2022. Veterinary Sciences. 2022. DOI: https://doi.org/10.3390/vetsci10010029

[12] Xu T, Hou C, Zhang Y, Li H, Chen X, Pan J, et al.. Simultaneous detection and genetic characterization of porcine circovirus 2 and 4 in Henan province of China.. Gene. 2021. DOI: https://doi.org/10.1016/j.gene.2021.145991

[13] Sun R, Liu H, Sun S, Wang Y, Shan Y, Li X, et al.. Development of a duplex real-time recombinase aided amplification assay for the simultaneous and rapid detection of PCV3 and PCV4. Virology Journal. 2025. DOI: https://doi.org/10.1186/s12985-025-02625-w

[14] Crossan C, Scobie L, Godwin J, Hunter J, Hawkes T, Dalton H. Hepatitis E Virus and Porcine-derived Heparin. Emerging Infectious Diseases. 2013. DOI: https://doi.org/10.3201/eid1904.121792

[15] Qi W, Zhu R, Bao C, Xiao J, Liu B, Sun M, et al.. Porcine circovirus type 2 promotes Actinobacillus pleuropneumoniae survival during coinfection of porcine alveolar macrophages by inhibiting ROS production.. Veterinary Microbiology. 2019. DOI: https://doi.org/10.1016/J.VETMIC.2019.04.028

[16] Tregaskis PL, Staines A, Gordon A, Sheridan P, McMenamy M, Duffy C, et al.. Co-infection Status of Novel Parvovirus's (PPV2 to 4) with Porcine Circovirus 2 in Porcine Respiratory Disease Complex and Porcine Circovirus Associated Disease from 1997-2012.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13846

[17] Das T, Sethi M, John J, Tomar N, Chavan AS, Pathak M, et al.. Pathology of PMWS Associated with Classical Swine Fever Virus, Porcine Parvo Virus and Multidrug Resistant Enteric Escherichia coli Infections in an Organized Swine Farm, Rajasthan, India. Indian Journal of Animal Research. 2022. DOI: https://doi.org/10.18805/ijar.b-4743

[18] Chen X, Shi X, Gan F, Huang D, Huang K. Glutamine starvation enhances PCV2 replication via the phosphorylation of p38 MAPK, as promoted by reducing glutathione levels. Veterinary Research. 2015. DOI: https://doi.org/10.1186/s13567-015-0168-1

[19] Roest H, Solt CBv, Tilburg J, Klaassen C, Hovius EKE, Roest F, et al.. Search for Possible Additional Reservoirs for Human Q Fever, the Netherlands. Emerging Infectious Diseases. 2013. DOI: https://doi.org/10.3201/eid1905.121489

[20] Mikhaleva TV, Konnova SS. Prevention of respiratory diseases of pigs of viral-bacterial etiology in conditions of import substitution. Veterinary Science Today. 2025. DOI: https://doi.org/10.29326/2304-196x-2025-14-1-32-39

[21] Chin P, Lambert C, Beurdelay P, Charlebois RL, Colinet A, Eloit M, et al.. Virus detection by short read high throughput sequencing in a high virus low cellular background. npj Vaccines. 2025. DOI: https://doi.org/10.1038/s41541-025-01104-1

[22] Jiao Q, Yang L, Liu X, Wen Y, Tian L, Qian P, et al.. Isolation and pathogenicity of porcine circovirus type 2 in mice from Guangxi province, China. Virology Journal. 2023. DOI: https://doi.org/10.1186/s12985-023-02161-5

[23] Pfankuche V, Bodewes R, Hahn K, Puff C, Beineke A, Habierski A, et al.. Porcine Bocavirus Infection Associated with Encephalomyelitis in a Pig, Germany. Emerging Infectious Diseases. 2016. DOI: https://doi.org/10.3201/eid2207.152049

[24] Janetanakit T, Lumyai M, Bunpapong N, Boonyapisitsopa S, Chaiyawong S, Nonthabenjawan N, et al.. Porcine Deltacoronavirus, Thailand, 2015. Emerging Infectious Diseases. 2016. DOI: https://doi.org/10.3201/eid2204.151852

[25] Li C, Gong B, Sun Q, Xu H, Zhao J, Xiang L, et al.. First Detection of NADC34-like PRRSV as a Main Epidemic Strain on a Large Farm in China. Pathogens. 2021. DOI: https://doi.org/10.3390/pathogens11010032

[26] Fowler H, Brown P, Rovira A, Shade BN, Klammer K, Smith KE, et al.. Streptococcus suis Meningitis in Swine Worker, Minnesota, USA. Emerging Infectious Diseases. 2013. DOI: https://doi.org/10.3201/EID1902.120918

[27] Kanobana K, Ruiz A, Rojas L, Andrade R, Rosado F, Polman K, et al.. Taenia solium Cysticercosis: The Case of Cuba. PLoS Neglected Tropical Diseases. 2013. DOI: https://doi.org/10.1371/journal.pntd.0002202

[28] Lloren KKS, Lee J. Live-Attenuated Salmonella-Based Oral Vaccine Candidates Expressing PCV2d Cap and Rep by Novel Expression Plasmids as a Vaccination Strategy for Mucosal and Systemic Immune Responses against PCV2d. Vaccines. 2023. DOI: https://doi.org/10.3390/vaccines11121777

[29] Buzun A, Kolchyk O, Stegniy M, Bobrovitska IA, Stegniy A. Biotechnological aspects of Amixin® application as an antiviral drug for treatment of pigs and chicken. . 2015. DOI: https://doi.org/10.36016/jvmbbs-2015-1-4-2